ALS Trials in Phoenix, United States
Conditions / ALS / Phoenix, United States
Research into ALS spans multiple therapeutic approaches and trial phases.
10 total trials for this combination
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT04165824 | Safety Study of Oral Edaravone Administered in Subjects With ALS | COMPLETED | PHASE3 |
| NCT02469896 | A Trial of Tocilizumab in ALS Subjects | COMPLETED | PHASE2 |
| NCT02819765 | Deep Phenotyping in Patients With ALS | COMPLETED | — |
| NCT04569084 | Efficacy and Safety Study of Oral Edaravone Administered in Subjects With ALS | TERMINATED | PHASE3 |
| NCT03868345 | Speech Analysis in ALS Patients | COMPLETED | — |
| NCT01495390 | A Longitudinal Study of Amyotrophic Lateral Sclerosis (ALS) Biomarkers | COMPLETED | — |
| NCT03488524 | Open Label Extension Study of AMX0035 in Patients With ALS | COMPLETED | PHASE2 |
| NCT04248465 | An Efficacy and Safety Study of Ravulizumab in ALS Participants | TERMINATED | PHASE3 |
| NCT00349622 | Clinical Trial Ceftriaxone in Subjects With ALS | COMPLETED | PHASE3 |
| NCT04259255 | Radicava® (Edaravone) Findings in Biomarkers From ALS (REFINE-ALS) | UNKNOWN | — |